Holen Sie sich die Stockscreener-App
0.677
0.44%
-0.003
Handel nachbörslich:
2.66
1.983
+292.91%
Schlusskurs vom Vortag:
$0.68
Offen:
$0.673
24-Stunden-Volumen:
1.58M
Relative Volume:
0.64
Marktkapitalisierung:
$7.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-0.0978
EPS:
-6.9236
Netto-Cashflow:
$-10.11M
1W Leistung:
-17.15%
1M Leistung:
+5.78%
6M Leistung:
-68.22%
1J Leistung:
-73.45%
1-Tages-Spanne:
$0.61
$0.69
1-Wochen-Bereich:
$0.61
$0.8583
52-Wochen-Spanne:
$0.54
$3.85
Gt Biopharma Inc Stock (GTBP) Company Profile
Firmenname
Gt Biopharma Inc
Sektor
Branche
Telefon
(800) 304-9888
Adresse
505 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie GTBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.65 | 4.83B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.66 | 416.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.75 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
8.57 | 357.42M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.51 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | ROTH MKM | Buy |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-17 | Eingeleitet | ROTH Capital | Buy |
Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten
Market Rankings: Will GT Biopharma Inc stock keep outperforming rivalsPortfolio Performance Report & Safe Investment Capital Preservation Plans - moha.gov.vn
Is GT Biopharma Inc. stock supported by innovation pipelineEarnings Recap Summary & Fast Moving Market Watchlists - ulpravda.ru
Why GT Biopharma Inc. stock attracts high net worth investorsCushioning Options Review & how to pick the right width - ulpravda.ru
Will GT Biopharma Inc. (OXIA) stock keep high P E multiples2025 Top Gainers & High Accuracy Investment Signals - ulpravda.ru
GT Biopharma shares advance as flagship GTB 3650 trial escalates to next dose level - MSN
Is GT Biopharma Inc. stock supported by strong cash flows2025 Momentum Check & AI Powered Market Entry Ideas - ulpravda.ru
Is GT Biopharma Inc. stock supported by strong fundamentalsJuly 2025 WrapUp & Expert-Curated Trade Recommendations - ulpravda.ru
Can GT Biopharma Inc. stock resist market sell offsJuly 2025 Trends & Consistent Profit Trading Strategies - ulpravda.ru
How interest rate cuts could boost GT Biopharma Inc. stockJuly 2025 Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Can GT Biopharma Inc. stock double in next 5 yearsTrend Reversal & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Workboat Indexes - FinancialContent
Is GT Biopharma Inc. stock attractive for retirement portfolios2026 world cup usa national team semifinals young talents build up play odds analysis analysis - ulpravda.ru
Los Angeles Daily NewsGT Biopharma, Inc.Common Stock (Nasdaq:GTBP) Stock Quote - FinancialContent
Fibonacci Retracement Aligns with Support in Ballarpur Industries LimitedReal Estate Investment Trusts & Affordable Trading Plans - bollywoodhelpline.com
Big Money Moves: Why GT Biopharma Inc stock attracts high net worth investorsBear Alert & Stepwise Trade Execution Plans - moha.gov.vn
GT Biopharma Earnings Notes - Trefis
GTBP overperforms with a 10.54 increase in share price - uspostnews.com
GT Biopharma, Inc.Common Stock (NQ: GTBP - FinancialContent
Is GT Biopharma Inc. (OXIA) stock trading at attractive multiplesMomentum Trading Signals & Small Budget Trading Ideas - Bollywood Helpline
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Risk Report: Why GT Biopharma Inc OXIA stock is a strong analyst pickWatch List & Advanced Swing Trade Entry Alerts - moha.gov.vn
Is GT Biopharma Inc. (OXIA) stock suitable for passive index fundsQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
Can GT Biopharma Inc. (OXIA) stock sustain breakout momentumRate Cut & Daily Entry Point Alerts - Улправда
Will GT Biopharma Inc. stock deliver long term returnsCEO Change & Safe Investment Capital Preservation Plans - Улправда
Why retail investors pile into GT Biopharma Inc. stockWeekly Trade Review & Low Drawdown Investment Ideas - Улправда
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - The Globe and Mail
Why GT Biopharma Inc. (OXIA) stock is a strong analyst pickQuarterly Earnings Summary & Consistent Income Trade Recommendations - DonanımHaber
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 - Sahm
Is GT Biopharma Inc. (OXIA) stock safe for risk averse investorsTrade Exit Summary & Risk Controlled Swing Trade Alerts - DonanımHaber
S P Trends: Is GT Biopharma Inc. (OXIA) stock safe for risk averse investorsInflation Watch & Reliable Intraday Trade Alerts - DonanımHaber
How GT Biopharma Inc. (OXIA) stock correlates with oil markets2025 Winners & Losers & Community Consensus Trade Signals - ulpravda.ru
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis - GlobeNewswire Inc.
GT Biopharma Inc Stock Analysis and ForecastEarnings Surprise Analysis & Free Get High Impact Recommendations - earlytimes.in
GT Biopharma Inc OXIA Stock Analysis and ForecastStraddle and Strangle Trades & Free High Yield Portfolio Picks - earlytimes.in
Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com
GT Biopharma, Inc. Reports Continued Progress with Its Phase 1 Clinical Trial of GTB-3650 - marketscreener.com
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market - The Manila Times
What is GT Biopharma Inc (GTBP) Stock Return on Shareholders’ Capital? - setenews.com
GT Biopharma (GTBP) Stock Analysis Report | Financials & Insights - Benzinga
Why GT Biopharma Inc. (OXIA) stock could rally stronglyJuly 2025 Recap & Daily Price Action Insights - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - KamloopsBCNow
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points (2025-12-04) - Seeking Alpha
What technical charts say about GT Biopharma Inc. stockTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
What is the fair value estimate for GT Biopharma Inc. (OXIA) stock in 2025July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
The growth track for GT Biopharma Inc (GTBP) has changed recently - Setenews
What Wall Street predicts for GT Biopharma Inc. stock priceTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):